Skip to main content
SpringerLink
Log in

Levetiracetam

pronouncing a promising future

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Levetiracetam is a piracetam analogue which was originally intended as a nootropic. However, thanks to serendipity, the drug is now a promising new option for the treatment of epilepsy. It is currently at the final stage of the drug development process and has been filed for approval in both the US and Europe. Although not yet licensed, levetiracetam has aroused plenty of interest and at the 23rd International Epilepsy Congress [ Prague, Czech Republic; September 1999 ] it was discussed in detail.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Helen Commander
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Commander, H. Levetiracetam. Inpharma Wkly. 1214, 11–12 (1999). https://doi.org/10.2165/00128413-199912140-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199912140-00019

Keywords

Search

Navigation